1. Crown Castle delayed its earnings release to announce an $8.5 billion asset sale, aimed at debt reduction and stock buybacks, but this makes the company less attractive. 2. Despite a slight revenue beat, Q4 2024 results showed declines in key segments and a significant goodwill impairment charge, leading to a downgrade from 'strong buy' to 'buy'. 3. The asset sale will reduce debt and fund a share buyback, but the proceeds are disappointing, and the stock will appear more expensive post-transaction.